Heart valve repair device tracked for 10 years in new study

NCT ID NCT07413926

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study follows 110 patients who had mitral valve repair surgery using the Chord-X system to see how well the device holds up over 10 years. Researchers will check for return of moderate-to-severe mitral regurgitation and other safety issues. Participants agree to share their medical history and attend routine follow-up visits. The goal is to improve future care for people with leaky heart valves.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Chord-X system implant (a device to repair the mitral valve)
What this could lead to
If successful, this study could confirm that the Chord-X device provides lasting repair for mitral regurgitation, reducing the need for repeat surgeries.
What could go wrong
This is an observational follow-up study, not a controlled trial, so it cannot prove the device works better than alternatives. Results depend on routine clinic visits and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION (MR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Blackpool Victoria Hospital

    Blackpool, United Kingdom

  • Monasterio Foundation Heart Hospital

    Massa, Italy

  • St. Elizabeth Healthcare

    Edgewood, Kentucky, 41017, United States

  • The James Cook University Hospital

    Middlesbrough, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.